Practice Change in Surgical Treatment Strategies for Ischaemic Mitral Regurgitation and Late Outcomes

Yaerhim Shin1, John K French1, Mahnoor Mian2

  • 1Cardiothoracic Surgery and Cardiology Departments, Liverpool Hospital, South West Sydney, NSW, Australia; South West Sydney Clinical School, Faculty of Medicine, University of New South Wales, Sydney, NSW, Australia.

Heart, Lung & Circulation
|February 18, 2025
PubMed
Abstract

Insights

Surgical treatment for ischaemic mitral regurgitation (IMR) saw reduced procedures and repairs post-2014. While long-term outcomes remained similar, mitral regurgitation recurrence significantly improved with surgical intervention.

Area of Science:

  • Cardiology
  • Cardiac Surgery
  • Medical Devices

Background:

  • Ischaemic mitral regurgitation (IMR) is linked to poor prognosis due to myocardial remodeling.
  • Surgical intervention for IMR is evaluated against emerging non-surgical options for non-severe cases.
  • Clinical and echocardiographic outcomes of surgical IMR treatment are critical for patient management.

Purpose of the Study:

  • To assess surgical treatment patterns for IMR before and after 2014.
  • To compare clinical and echocardiographic outcomes between mitral valve (MV) repair and replacement for IMR.
  • To evaluate changes in MV procedure types and outcomes over two distinct time periods.

Main Methods:

  • Retrospective analysis of 106 patients undergoing MV procedures for IMR (2008-2020).
  • Data collected from patient records and linked with the National Death Index.
  • Primary outcome: MV surgery type; Secondary outcomes: survival, freedom from mortality and CHF readmission, comparing repair vs. replacement and pre/post-2014 periods.

Main Results:

  • MV procedures for IMR decreased post-2014 (4.2% to 2.0%), with a notable drop in MV repair rates (80.8% to 57.6%).
  • 10-year freedom from mortality and CHF readmission was superior with MV repair versus replacement.
  • Mitral regurgitation recurrence was significantly lower in the later period (2015-2020) compared to the earlier period (25.8% vs. 3.6%).

Conclusions:

  • A significant shift in surgical practice for IMR occurred post-2014, favoring conservative approaches.
  • Despite practice changes, overall long-term survival and CHF readmission rates remained consistent.
  • Surgical management, particularly MV repair, demonstrated improved rates of mitral regurgitation recurrence.

Related Concept Videos

Mitral Valve Prolapse II: Assessment and Management01:22

Mitral Valve Prolapse II: Assessment and Management

IntroductionA range of clinical features characterizes Mitral Valve Prolapse (MVP), but it is important to note that many individuals with MVP are asymptomatic and may remain so throughout their lives. For those who do exhibit symptoms, the following are the key clinical features:Palpitations: This is a common symptom where individuals feel an irregular or rapid heartbeat. Palpitations in MVP are often due to arrhythmias such as premature ventricular contractions or supraventricular tachycardia.
Mitral Regurgitation II: Clinical Features and Diagnostic Tests01:23

Mitral Regurgitation II: Clinical Features and Diagnostic Tests

Mitral regurgitation (MR) is a valvular heart disorder in which the mitral valve fails to close tightly, allowing blood to leak backward into the heart. Understanding the clinical manifestations, assessment, diagnostic findings, and medical management of MR is crucial to effectively managing affected patients.Clinical Manifestations of Mitral RegurgitationMitral regurgitation can be acute or chronic, each presenting differently and requiring different approaches:1. Acute Mitral...
Mitral Regurgitation III: Medical Management01:25

Mitral Regurgitation III: Medical Management

Mitral regurgitation (MR) is characterized by retrograde blood circulation from the left ventricle into the left atrium due to inadequate mitral valve closure. The severity of the condition, symptoms, and underlying cause determine treatment strategies.Monitoring and Pharmacological TreatmentPatients with mild to moderate MR typically do not need immediate intervention but regular monitoring to assess progression and guide treatment. Patients with mild MR should have an echocardiogram every 3-5...
Mitral Regurgitation IV: Nursing Management01:28

Mitral Regurgitation IV: Nursing Management

Mitral regurgitation (MR) is a condition where the mitral valve does not close properly, leading to the backward flow of blood from the left ventricle into the left atrium during systole. This condition can arise from various causes, including rheumatic fever, infective endocarditis, or degenerative valve disease. Effective nursing management is crucial to optimizing patient outcomes and involves comprehensive assessment and targeted interventions.Comprehensive Patient AssessmentA detailed...
Mitral Stenosis III: Medical Management01:26

Mitral Stenosis III: Medical Management

Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
Mitral Stenosis IV: Nursing Management01:27

Mitral Stenosis IV: Nursing Management

A comprehensive nursing assessment is essential for patients with valvular heart disease, which involves any dysfunction of the heart valves that could impact blood flow and overall heart function.Subjective Data Collection:Chief Complaint and Present Illness: Start with the patient's primary concerns, focusing on the onset, duration, and progression of cardiac symptoms such as dyspnea, fatigue, chest pain, and palpitations.Past Medical History: Collect detailed information on any previous...